PCA
BEAM icon

Prosperity Capital Advisors’s Beam Therapeutics BEAM Stock Holding History

Prosperity Capital Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Buy
+6,835
New +$206K 0.01% 386

Other funds holding BEAM

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
BFS
Beacon Financial Strategies Raleigh, North Carolina $201M AUM 19.14% 1-Year Est. Return
TWM
Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Prosperity Capital Advisors's BEAM Position: Q2 2026 in Review

Prosperity Capital Advisors opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 6,835 shares worth $235K. The stake represents 0.01% of the portfolio and ranks #386 among its holdings.

21 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Prosperity Capital Advisors held 6,835 shares of Beam Therapeutics worth $235K as of Q2 2026.
  • Beam Therapeutics was a new Prosperity Capital Advisors position in Q2 2026.
  • Beam Therapeutics made up 0.01% of Prosperity Capital Advisors's portfolio in Q2 2026, its #386 holding.
  • 21 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Prosperity Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.